Blog
1 Growth Stock That Could Double Again
From its initial public offering to its all-time high of $370.10 in August 2021, Carvana (NYSE: CVNA) saw its stock price skyrocket an incredible 3,200%. This performance crushed the Nasdaq
Buy These 2 Growth Stocks on the Dip
"Buying the dip" -- or purchasing stocks after prices have dropped -- is a time-honored strategy that many an investor has tried. When done correctly, buying the dip can be a great way to invest in
The Big Question for Goldman's CEO David Solomon
Toward the end of last year and at the start of this year, the investment banking powerhouse Goldman Sachs (NYSE: GS) indicated that it was planning to significantly scale back its consumer banking
Dogecoin: Bull vs. Bear
Despite getting its start as a spoof of Bitcoin, Dogecoin (CRYPTO: DOGE) wound up producing life-changing returns for investors who bought and sold the token at the right times. But the famous meme
Wish You'd Bought at the Bottom? Here's Why It's Not That Important.
There are many regrets you might have if you've been investing in stocks. Some are reasonable, and others not. For example, it's reasonable to regret selling a great-performing stock too soon
Why Should You Invest in Blue Chip Stocks?
There are a lot of different ways to invest in the stock market. A popular strategy is to focus on emerging, fast-growing disruptors that are innovating in expanding markets. While owning these
Wall Street Was Wrong About Rocket Lab USA. Here's What to Watch Now.
Investors didn't quite know what to make of Rocket Lab USA's (NASDAQ: RKLB) earnings report last week. On the one hand, the U.S.-New Zealand space stock beat on sales, reporting $51.8 million for
Sanofi Could Be on a Roll With a Strong Performance and Its Latest FDA Approval
French pharmaceutical company Sanofi (NASDAQ: SNY) is seeing a jump in its share price following major product news on Feb. 23. The company shared that the Food and Drug Administration (FDA) had
Want to Become a Stock Market Millionaire? This ETF Can Get You There.
Building a million-dollar portfolio may seem like an impossible goal that's reserved for only elite investors. But it's more attainable than you might think.
You don't need to be wealthy to make a
Why Sprouts Farmers Market Stock Is a No-Brainer Buy
Investing in the biggest players in the grocery market doesn't seem too appealing to me. Companies like Kroger already operate thousands of stores, and balance sheets are often loaded with debt
The Best Stocks to Buy With $1,000 Right Now
In tumultuous markets, long-term opportunities usually present themselves. Opportunities may arise in beaten-down stocks because of unique company-specific headwinds that may reverse in time. At
Not Loving Your Employer's 401(k)? Here's 1 Reason to Fund It Anyway
Building retirement savings is so important. Without a solid nest egg, you might really struggle financially once your time in the workforce comes to an end.
And if you're thinking you can just fall
Why Is BlackRock's Dividend So High?
The world's largest asset manager, BlackRock (NYSE: BLK), has one of the highest dividend payouts you'll see on the market.
BlackRock pays out an astronomical $5 per share dividend per quarter, or
2 Top Tech Stocks to Buy for the Long Haul
Tech stocks have been hit especially hard in the market downturn that started in early 2022. The Nasdaq Composite Index's losses roughly doubled the 8% decline in the S&P 500 in the past 12 months.
Could MercadoLibre Still Be a Bargain Stock After Rising 43% Already in 2023?
MercadoLibre (NASDAQ: MELI) recently reported its fourth-quarter earnings, and the results look pretty impressive. In this video, Matt Frankel, CFP®, discusses the results and why they make him want
Is Axsome Therapeutics Stock a Buy Now?
Even in a struggling stock market, it is possible to find stocks that perform exceptionally well. That's been the case for biotech company Axsome Therapeutics (NASDAQ: AXSM) over the past year, with
SpaceX Is Launching Fewer Starlinks, And That's Bad News for Amazon
Something amazing just happened at SpaceX -- and no, I'm not talking about Thursday's Crew-6 launch.
After not six, but actually seven successful launches (counting the 2020 Demo-2 mission)
What Do New NFTs Mean for Bitcoin's Future Valuation?
New non-fungible tokens (NFTs) from Bitcoin known as Ordinals continue to generate a tremendous amount of buzz, hype, and speculation. But what impact will they actually have on the valuation of
Annaly Capital Management vs. AGNC: Which Stock has the More Sustainable Dividend?
The mortgage real estate investment trusts (mREITs) Annaly Capital Management (NYSE: NLY) and AGNC Investment Corp (NASDAQ: AGNC) have become popular stocks since the pandemic due to their high
Where Should You Invest Right Now? Here's Warren Buffett's Advice.
Some believe that a new bull market is right around the corner. Others think a recession is on the way that could pull the stock market down. It seems as if the only thing that's certain is that
Nasdaq Bear Market: 3 Unstoppable Stocks Still Down 37% or More That You'll Regret Not Buying on the Dip
There's been plenty of speculation that a new bull market could be on the way. The Nasdaq Composite Index came tantalizingly close to reaching bull market levels only a few weeks ago.
For now
Is CVS Health a Good Dividend Stock to Buy Now?
Shares of CVS Health (NYSE: CVS) hit a high-water mark about a year ago, but it's fallen around 27% from its all-time high. Now, dividend growth investors are sniffing around this one-of-a-kind
At an All-Time Low, Is It Time to Give Up on Rivian Stock?
Rivian Automotive (NASDAQ: RIVN) crashed to a new all-time intraday low on Thursday after the electric pickup truck, SUV, and delivery van maker reported a wider-than-expected quarterly loss and
1 Growth Stock That Could Turn $200,000 Into $1 Million in a Decade
Experts believe artificial intelligence (AI) will have a profound impact on business productivity in the coming years. AI will accelerate software development, automate factory operations, and
2 Reasons to Buy Moderna Stock, and 1 Reason to Sell
Moderna (NASDAQ: MRNA) became a household name thanks to its quickly produced and approved coronavirus vaccine in 2020. Now that the pandemic is easing, it's reasonable to ask if there's still an


